436 related articles for article (PubMed ID: 21441353)
21. Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.
Tsujino K; Reed NI; Atakilit A; Ren X; Sheppard D
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L22-L31. PubMed ID: 27864286
[TBL] [Abstract][Full Text] [Related]
22. Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis.
Banerjee ER; Henderson WR
Stem Cell Res Ther; 2012 May; 3(3):21. PubMed ID: 22643035
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
Huang LS; Fu P; Patel P; Harijith A; Sun T; Zhao Y; Garcia JG; Chun J; Natarajan V
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
[TBL] [Abstract][Full Text] [Related]
25. Lung epithelial cell focal adhesion kinase signaling inhibits lung injury and fibrosis.
Wheaton AK; Agarwal M; Jia S; Kim KK
Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L722-L730. PubMed ID: 28283477
[TBL] [Abstract][Full Text] [Related]
26. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Hashimoto N; Phan SH; Imaizumi K; Matsuo M; Nakashima H; Kawabe T; Shimokata K; Hasegawa Y
Am J Respir Cell Mol Biol; 2010 Aug; 43(2):161-72. PubMed ID: 19767450
[TBL] [Abstract][Full Text] [Related]
27. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome.
Young LR; Gulleman PM; Short CW; Tanjore H; Sherrill T; Qi A; McBride AP; Zaynagetdinov R; Benjamin JT; Lawson WE; Novitskiy SV; Blackwell TS
JCI Insight; 2016 Oct; 1(17):e88947. PubMed ID: 27777976
[TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts.
Takenouchi Y; Kitakaze K; Tsuboi K; Okamoto Y
Exp Cell Res; 2020 Jun; 391(2):112010. PubMed ID: 32305327
[TBL] [Abstract][Full Text] [Related]
30. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
[TBL] [Abstract][Full Text] [Related]
31. Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.
Zhou Q; Chen T; Zhang W; Bozkanat M; Li Y; Xiao L; van Breemen RB; Christman JW; Sznajder JI; Zhou G
Am J Respir Cell Mol Biol; 2016 May; 54(5):728-39. PubMed ID: 26488390
[TBL] [Abstract][Full Text] [Related]
32. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
33. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
35. Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats.
Khalil N; O'Connor RN; Flanders KC; Shing W; Whitman CI
Am J Physiol; 1994 Nov; 267(5 Pt 1):L498-507. PubMed ID: 7526703
[TBL] [Abstract][Full Text] [Related]
36. The role of the receptor for advanced glycation end-products in lung fibrosis.
He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
[TBL] [Abstract][Full Text] [Related]
37. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
38. Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis.
Christensen PJ; Bailie MB; Goodman RE; O'Brien AD; Toews GB; Paine R
Am J Physiol Lung Cell Mol Physiol; 2000 Sep; 279(3):L487-95. PubMed ID: 10956623
[TBL] [Abstract][Full Text] [Related]
39. The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
Funke M; Zhao Z; Xu Y; Chun J; Tager AM
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):355-64. PubMed ID: 22021336
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
